EQT

About EQT

EQT is a Swedish listed global alternative investment firm with €269 billion of total assets under management as of December 2024 (€136 billion fee-generating), headquartered in Stockholm and listed on Nasdaq Stockholm following its 2019 IPO. The firm was founded in 1994 by SEB, AEA Investors and the Wallenberg-controlled Investor AB, with the modern thematic active-ownership model conceived in 1993 by Conni Jonsson and Claes Dahlbäck and inspired by the Wallenberg family's responsible ownership philosophy. Investor AB and founding partners remain anchor shareholders alongside institutional and public market investors. EQT operates a global multi-strategy platform spanning private equity, infrastructure, real estate, life sciences and ventures.

Investment thesis

EQT deploys capital through more than 25 active flagship vehicles across large-cap and mid-market buyout, growth, life sciences (LSP), infrastructure (Value-Add, Active Core, Transition), real estate and ventures, with capital allocated to healthcare, technology, industrial technology, services, environmental and energy transition and consumer verticals. Geographic deployment spans Europe, North America and Asia-Pacific, supported by a Nordic-rooted operating heritage and sector-themed global platforms. The active-ownership model combines deep sector expertise with operational improvement teams, ESG integration and global cross-portfolio knowledge networks. Recent flagship vintages include EQT X (private equity), EQT Infrastructure VI, EQT Active Core Infrastructure, BPEA Private Equity Fund VIII (Asia) and LSP 6 (life sciences).

Recent activity

Recent realised exits include realisations across healthcare (2025), software and technology (2025), infrastructure (2025) and financial services (2025), reflecting record exit momentum even under tight market conditions. Recent acquisitions include Coller Capital (secondaries asset manager, 2026), NEOGOV (HR software, 2025) and Crown Castle small cells (digital infrastructure, 2025). EQT continues to deploy capital across its global flagship strategies while expanding the secondaries franchise via the Coller Capital acquisition, with strong fundraising momentum across infrastructure and life sciences. Detailed buyer names and multiple data available on Pro at €49/month.